MedTrace Logo

Alster Stem Cells - Intramyocardial Stem Therapy

NCT00939042 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-10-06

No results posted yet for this study

Summary

Study to assess the efficacy of intramyocardial bone marrow derived mononuclear cell therapy concerning left ventricular ejection fraction as measured by echocardiography.

Conditions

  • Acute Myocardial Infarction
  • Early Left Ventricular Dysfunction

Interventions

PROCEDURE

Percutaneous Coronary Intervention

common Percutaneous Coronary Intervention

PROCEDURE

BMNC therapy

Injection of BMNC after common PCI

Sponsors & Collaborators

  • Asklepios proresearch

    lead INDUSTRY

Principal Investigators

  • Karl-Heinz Kuck, MD, PhD · Asklepios Klinik St. Georg, Department of Cardiology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00939042 on ClinicalTrials.gov